World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
69
Citations
12521
World Ranking
7583
National Ranking
3446

Mark S. Sands publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Mark S. Sands sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 195 publications — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Mark S. Sands D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Mark S. Sands sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 69 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Mark S. Sands is affiliated with Washington University in St. Louis in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a particular focus on subfields such as Physiology, Molecular Biology, Cell Biology, Epidemiology, and Surgery.

The main topics of Mark S. Sands's research include:

  • Lysosomal Storage Disorders Research
  • Cellular transport and secretion
  • Trypanosoma species research and implications
  • RNA regulation and disease
  • Glycogen Storage Diseases and Myoclonus
  • Adenosine and Purinergic Signaling
  • Carbohydrate Chemistry and Synthesis

Mark S. Sands has published numerous papers in several scientific venues. Frequent publication venues include:

  • Molecular Genetics and Metabolism
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Clinical Investigation
  • Molecular Therapy
  • Scientific Reports

Recent papers authored or co-authored by Mark S. Sands cover a range of topics, especially related to Krabbe disease and gene therapy. Notable publications include:

  • "Krabbe disease: New hope for an old disease," 2021, Neuroscience Letters
  • "Krabbe disease successfully treated via monotherapy of intrathecal gene therapy," 2020, Journal of Clinical Investigation
  • "Macrophage secretion of miR-106b-5p causes renin-dependent hypertension," 2020, Nature Communications
  • "Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe Disease," 2020, Molecular Therapy
  • "Waning efficacy in a long-term AAV-mediated gene therapy study in the murine model of Krabbe disease," 2021, Molecular Therapy

Their frequent collaborators include:

  • Jonathan D. Cooper
  • Hemanth R. Nelvagal
  • Elizabeth M. Eultgen
  • Joshua T. Dearborn
  • Keigo Takahashi

Over the course of their career, Mark S. Sands has contributed extensively to the understanding of lysosomal storage disorders, particularly in relation to gene therapy approaches. This work is situated within a broader context of molecular genetics and metabolic research that informs the diagnosis and treatment of inherited metabolic diseases.

Best Publications

  • AAV Vector Integration Sites in Mouse Hepatocellular Carcinoma

    Anthony Donsante;Daniel G. Miller;Yi Li;Carole Vogler

  • Gene therapy for lysosomal storage diseases.

    Mark S. Sands;Beverly L. Davidson

  • CMV-β-Actin Promoter Directs Higher Expression from an Adeno-Associated Viral Vector in the Liver than the Cytomegalovirus or Elongation Factor 1α Promoter and Results in Therapeutic Levels of Human Factor X in Mice

    Lingfei Xu;Thomas Daly;Cuihua Gao;Terence R. Flotte

  • Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells.

    Margaret A. Young;David E. Larson;Chiao Wang Sun;Daniel R. George

  • Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer.

    John H. Wolfe;Mark S. Sands;Jane E. Barker;Babette Gwynn

  • Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease

    Thomas M. Daly;Carole Vogler;Beth Levy;Mark E. Haskins

  • In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models.

    Todd E. Meyerrose;Daniel A. De Ugarte;A. Alex Hofling;Phillip E. Herrbrich

  • ENZYME REPLACEMENT THERAPY FOR MURINE MUCOPOLYSACCHARIDOSIS TYPE VII

    M S Sands;C Vogler;J W Kyle;J H Grubb

  • Marrow Stromal Cells and Osteoclast Precursors Differentially Contribute to TNF-α-Induced Osteoclastogenesis In Vivo

    Hideki Kitaura;Mark S. Sands;Kunihiko Aya;Ping Zhou

  • Recombinant Adeno-Associated Viral Integration and Genotoxicity: Insights from Animal Models

    Randy J Chandler;Mark S Sands;Charles P Venditti

  • Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis

    Catherine Kielar;Lucy Maddox;Ellen Bible;Charlie C Pontikis

  • Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice.

    Thomas M. Daly;Torayuki Okuyama;Carole Vogler;Mark E. Haskins

  • A single-base-pair deletion in the beta-glucuronidase gene accounts for the phenotype of murine mucopolysaccharidosis type VII.

    Mark S. Sands;Edward H. Birkenmeier

  • Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates.

    M S Sands;J E Barker;C Vogler;B Levy

  • Clinical course of sly syndrome (mucopolysaccharidosis type VII)

    Adriana M Montaño;Ngu Lock-Hock;Robert D Steiner;Brett H Graham

  • Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function.

    L H O'Connor;L C Erway;C A Vogler;W S Sly

  • Central amygdala glucocorticoid receptor action promotes fear-associated CRH activation and conditioning

    Benedict J. Kolber;Marie S. Roberts;Maureen P. Howell;David F. Wozniak

  • CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis.

    Megan A. Griffey;David Wozniak;Michael Wong;Ellen Bible

  • Niemann-Pick C1 protects against atherosclerosis in mice via regulation of macrophage intracellular cholesterol trafficking.

    Jessie R. Zhang;Trey Coleman;S. Joshua Langmade;David E. Scherrer

  • VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients.

    Pampee P. Young;A. Alex Hofling;Mark S. Sands

Frequent Co-Authors

Jonathan D. Cooper
Jonathan D. Cooper Washington University in St. Louis
William S. Sly
William S. Sly Saint Louis University
Kevin K. Ohlemiller
Kevin K. Ohlemiller Washington University in St. Louis
Daniel S. Ory
Daniel S. Ory Washington University in St. Louis
Jan A. Nolta
Jan A. Nolta University of California, Davis
Jin-Moo Lee
Jin-Moo Lee Washington University in St. Louis
Thomas H. Gillingwater
Thomas H. Gillingwater University of Edinburgh
John H. Wolfe
John H. Wolfe University of Pennsylvania
Erik D. Herzog
Erik D. Herzog Washington University in St. Louis
Alexei V. Demchenko
Alexei V. Demchenko Saint Louis University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Expanding your education in Biology and Biochemistry can open doors to a wide range of online degree programs and diverse career options within the health sciences. With flexible online study, it’s possible to pursue advanced qualifications while balancing professional or personal commitments.

If you're interested in clinical leadership, the best online dnp programs offer pathways to top-level nursing roles without traditional clinical requirements. For those drawn to the business and administrative side of healthcare, the best doctorate of healthcare administration programs prepare graduates for executive and management opportunities.

Students passionate about pharmacy can take advantage of flexible pharmd online programs to earn a doctorate in pharmacy remotely. If you’re interested in wellness, movement science, or sports medicine, an online bachelor's degree in exercise science offers a strong scientific foundation.

These online programs are designed to help you advance your expertise, qualify for new career paths, and make a meaningful impact across the health and science sectors.

Best Scientists Citing Mark S. Sands

Trending Scientists

Recently Published Articles